Reduced Activity of AMP-Activated Protein Kinase Protects against Genetic Models of Motor Neuron Disease
A growing body of research indicates that amyotrophic lateral sclerosis (ALS) patients and mouse models of ALS exhibit metabolic dysfunction. A subpopulation of ALS patients possesses higher levels of resting energy expenditure and lower fat-free mass compared to healthy controls. Similarly, two mut...
Main Authors: | Lim, M. A., Selak, M. A., Xiang, Z., Krainc, Dimitri, Neve, Rachael L., Kraemer, B. C., Watts, J. L., Kalb, R. G. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Article |
Language: | en_US |
Published: |
Society for Neuroscience
2012
|
Online Access: | http://hdl.handle.net/1721.1/72527 https://orcid.org/0000-0002-3854-5968 |
Similar Items
-
The role of AMP-activated protein kinase in obesity.
by: Kola, B, et al.
Published: (2008) -
Targeting AMP-activated protein kinase in sepsis
by: Tetsuya Yumoto, et al.
Published: (2024-10-01) -
Protocol to investigate Parkinson’s patient-derived dopaminergic neurons by live-cell microscopy and oxidized dopamine assays
by: Pingping Song, et al.
Published: (2024-03-01) -
Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action
by: A. M. Mkrtumyan, et al.
Published: (2023-12-01) -
The role of AMP-activated protein kinase in the metabolic syndrome
by: Christ-Crain, M, et al.
Published: (2007)